Prochlorperazine injection
Products billed under this code include Prochlorperazine Edisylate.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Prochlorperazine Edisylate.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Prochlorperazine Edisylate | Hikma Pharmaceuticals USA Inc. | 00641-6135-25 | 25 | $61.875 |
| Prochlorperazine Edisylate | Nexus Pharmaceuticals, LLC | 14789-0700-02 | 10 | $24.75 |
| Prochlorperazine Edisylate | Heritage Pharmaceuticals Inc. | 23155-0294-41 | 25 | $61.875 |
| Prochlorperazine Edisylate | Heritage Pharmaceuticals Inc. | 23155-0294-42 | 10 | $24.75 |
| Prochlorperazine Edisylate | Heritage Pharmaceuticals Inc. | 23155-0497-42 | 10 | $24.75 |
| Prochlorperazine Edisylate | Heritage Pharmaceuticals Inc. | 23155-0523-41 | 10 | $24.75 |
| Prochlorperazine Edisylate | Sagent Pharmaceuticals | 25021-0790-02 | 10 | $24.75 |
| Prochlorperazine Edisylate | Sagent Pharmaceuticals | 25021-0790-03 | 25 | $61.875 |
| Prochlorperazine Edisylate | Baxter Healthcare Corporation | 43066-0090-25 | 25 | $61.875 |
| Prochlorperazine Edisylate | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1558-03 | 25 | $61.875 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Prochlorperazine Edisylate | Caplin Steriles USA Inc. | 65145-0119-10 | 10 | $24.75 |
| Prochlorperazine Edisylate | Mylan Institutional LLC | 67457-0640-02 | 25 | $61.875 |
| Prochlorperazine Edisylate | Mylan Institutional LLC | 67457-0640-99 | 10 | $24.75 |
| Prochlorperazine Edisylate | Somerset Pharma, LLC | 70069-0371-25 | 25 | $61.875 |
| Prochlorperazine Edisylate | Athenex Pharmaceutical Division, LLC | 70860-0778-02 | 10 | $24.75 |
| Prochlorperazine Edisylate | Fosun Pharma USA Inc. | 72266-0204-10 | 10 | $24.75 |
| Prochlorperazine Edisylate | Civica, Inc. | 72572-0580-25 | 25 | $61.875 |
| Prochlorperazine Edisylate | Avenacy Inc. | 83634-0778-02 | 10 | $24.75 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.475 | −$0.287 | 10 MG | Prochlorperazine injection | v1, posted September 17, 2026 |
| 3Q26 | $2.762 | −$0.57 | 10 MG | Prochlorperazine injection | v1, posted September 15, 2026 |
| 2Q26 | $3.332 | +$0.811 | 10 MG | Prochlorperazine injection | v1, posted September 15, 2026 |
| 1Q26 | $2.521 | +$0.712 | 10 MG | Prochlorperazine injection | v1, posted September 15, 2026 |
| 4Q25 | $1.809 | −$0.714 | 10 MG | Prochlorperazine injection | v1, posted September 8, 2026 |
| 3Q25 | $2.523 | −$0.394 | 10 MG | Prochlorperazine injection | v1, posted March 10, 2026 |
| 2Q25 | $2.917 | −$0.036 | 10 MG | Prochlorperazine injection | v1, posted March 10, 2026 |
| 1Q25 | $2.953 | −$0.708 | 10 MG | Prochlorperazine injection | v1, posted December 19, 2025 |
| 4Q24 | $3.661 | +$0.017 | 10 MG | Prochlorperazine injection | v1, posted June 11, 2025 |
| 3Q24 | $3.644 | −$0.30 | 10 MG | Prochlorperazine injection | v1, posted June 11, 2025 |
| 2Q24 | $3.944 | +$0.515 | 10 MG | Prochlorperazine injection | v1, posted March 11, 2025 |
| 1Q24 | $3.429 | +$0.581 | 10 MG | Prochlorperazine injection | v1, posted December 19, 2024 |
| 4Q23 | $2.848 | −$0.166 | 10 MG | Prochlorperazine injection | v1, posted October 10, 2024 |
| 3Q23 | $3.014 | +$0.036 | 10 MG | Prochlorperazine injection | v1, posted June 5, 2024 |
| 2Q23 | $2.978 | +$0.027 | 10 MG | Prochlorperazine injection | v1, posted February 23, 2024 |
| 1Q23 | $2.951 | −$1.243 | 10 MG | Prochlorperazine injection | v1, posted December 6, 2023 |
| 4Q22 | $4.194 | +$0.199 | 10 MG | Prochlorperazine injection | v1, posted June 22, 2023 |
| 3Q22 | $3.995 | +$0.247 | 10 MG | Prochlorperazine injection | v1, posted June 9, 2023 |
| 2Q22 | $3.748 | −$0.438 | 10 MG | Prochlorperazine injection | v1, posted December 14, 2022 |
| 1Q22 | $4.186 | −$0.557 | 10 MG | Prochlorperazine injection | v1, posted June 8, 2022 |
| 4Q21 | $4.743 | −$0.439 | 10 MG | Prochlorperazine injection | v1, posted June 2, 2022 |
| 3Q21 | $5.182 | +$0.118 | 10 MG | Prochlorperazine injection | v1, posted June 2, 2022 |
| 2Q21 | $5.064 | −$0.008 | 10 MG | Prochlorperazine injection | v1, posted March 1, 2022 |
| 1Q21 | $5.072 | – | 10 MG | Prochlorperazine injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.